chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client c/o numbness in the jaw.  Client seen and assessed by EMT and vitals are BP 120/80, HR 78, O2 98%.  During assessment client stated that she had the same reaction when first dose was received.  Client advised to contact PCP if symptoms worsen.  Client verbalized understanding.
Admitted to Hospital with body ache and fever.  Found to be COVID positive in ED.  Symptoms started 5 days prior. He had a chest x-ray done, which was consistent with retrocardiac air-space opacity, which may represent possible pneumonia/atelectasis.  The patient was started on antibiotics, admitted to COVID unit.  Dx COVID pneumonitis, COVID tracheobronchitis.   Note: patient was previously vaccinated with Pfizer COVID19 vaccine; 1st dose 1/16/21 and 2nd dose 2/6/21. 8/2/21: patient discharged.
This spontaneous report was received from a nurse and refers to a 23-year-old female patient. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unspecified date in April 2018, the patient was vaccinated with PROQUAD for prophylaxis (dose, frequency, lot #, and expiration date were not reported). The patient was inadvertently vaccinated as her titers for measles, mumps, rubella and varicella were all negative. Adverse effects were not reported. Outcome of event was not reported.
Child had DTaP/IPV morning 9/19. Reports that Saturday evening Mom took off his shirt and observed swelling from axilla to elbow of left arm, redness, hot and hard to touch. T 100.5. Dr's office nurse recommended to give Benadryl and Motrin and to see Dr in morning if not better. Saw Dr., 9/21. Dr Dx child with Erysipelas infection and prescribed antibiotic.
Patient called 11/3/22 at approximately 3 PM. Patient reported local swelling, pain, and feeling warm to the touch starting around 10 PM on 11/2/22.  Patient had been putting ice on the location.
fussy not himself, lethargic, hypotonic 4-5hr p/vax;fever at home;
Super sick headache chills sweats fever muscle pain and exhaustion for 32 hours after each vaccine.
Full body red raised rash and hives developed. Rash not near injection site. The rash developed 10 days after second dose/injection. Fatigue and low fever (99.5) accompanied the rash.
Red, swollen on left deltoid area 2" X 4" at largest X 4 days.
Extensive local allergic response with erythema, mild induration, vesicle at site of injection.
Client states approximately 20 mins after receiving vaccine she became dizzy and vision was blurry. She states she vomited 7 times throughout the day. She states she was going to the DR
No adverse outcome. When Vaccine ordered and given there was no existing record in medical record or Immunization Record) of any vaccination received. RN asked patient and patient denied having had one. Later discovered patient had gotten a vaccine 12 days prior at her church.
This spontaneous report as received from a vaccine coordinator refers to multiple patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # L016429, expiration date 09-AUG-2017 (dose and route of administration were not provided). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 28.4 degrees Fahrenheit for 2 days, 21 hours, 30 minutes. Data logger was involved. There was no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
Breakthrough case admission after 3 vaccines Moderna 9/6/21 lot# 088D21A;  Pfizer 3/7/22 lot# FK9729;  Moderna 9/26/22 Lot# AS7163B
ACUTE NON ST ELEVATION MI 3/15/2022 NONTRAUMATIC ACUTE KIDNEY INJURY  ACUTE RESPIRATORY FAILURE 3/15/2022 NONTRAUMATIC ACUTE KIDNEY INJURY  HYPOXIA 3/15/2022 NONTRAUMATIC ACUTE KIDNEY INJURY  ACUTE NON ST ELEVATION MI 3/15/2022 FAILURE TO THRIVE SYNDROME, ADULT  ACUTE RESPIRATORY FAILURE 3/15/2022 FAILURE TO THRIVE SYNDROME, ADULT  HYPOXIA 3/15/2022 FAILURE TO THRIVE SYNDROME, ADULT
three red streaks below site little more than inch long and half inch wide, feels v warm, painful touching and uses of L hand
Tinnitus; having an inflammatory reaction; I got no reaction except the sore arm on the 27th; This is a spontaneous report from a contactable nurse (patient). A 67-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown [It was hard to read, patient believe it was EN6203-not clarified]) via an unspecified route of administration on 27Feb2021 (at the age of 67-year-old) as single dose for COVID-19 immunisation. Patient had no medical history. Concomitant/other medications included Supplements, Multivitamins (unspecified). On 27Feb2021 the patient experienced sore arm. On an unspecified date patient experienced tinnitus, inflammatory reaction. Patient stated that she was still experiencing them (Adverse event), but they were not as severe at all or did not make the patient feel like she was going to die now. Patient was wondering if Pfizer was collecting information from people on any chronic adverse effects from getting the vaccine earlier this year. Patient knows of a handful of people who have experienced what she was experiencing with the tinnitus. Patient asked, how was Pfizer approving the booster doses and asked if she were to receive the Flu vaccine would, since having such a reaction to the Pfizer vaccine and having an inflammatory reaction could that make it worse? Patient stated her doctors told her that there was no data on this yet, so they do not have an answer for her, and patient needed advice on getting the flu vaccine. Outcome of the event pain in arm was not resolved, tinnitus and inflammation were unknown.
Within hours of admin., injection site started to swell. Swelling continued over next several days -> to elbow. No rash. No fever. Area pink. Rec. to tx with ibuprofen and cool compress. CB if no improve or worsens.
Woke up around 4am this morning and had vertigo associated with nausea when lying on the left or right side.  Ive eaten and drank a glass of water and still have general sense of feeling spacy and slight nausea. BP normal upon checking today.
This spontaneous report was received from a consumer who is the wife of a 79-year-old male patient. Information on the patient's pertinent medical history included diabetes which was well controlled (diabetes mellitus). The patient's concomitant medications included GLUMETZA, omeprazole and simvastatin. The patient's historical drug included PREVNAR 13. The patient had no known drug reactions/allergies. On 06-AUG-2018, the patient was vaccinated with PNEUMOVAX 23 standard dosage of 0.5 ml (lot # N010105, expiry date was not reported) intramuscular in the left arm for recommended for age group. On 06-AUG-2018, not long after receiving the vaccine, the patient started having inflammation at the site of injection (vaccination site inflammation) and there was a significant pain in the arm of the injection (pain in extremity). Later in the night of the same day, the patient developed a high fever (pyrexia), aching throughout his body, felt like he was getting the flu (influenza like illness), he was shivering (chills) and had poor sleep (poor quality sleep). On an unknown date in August 2018, the patient sought medical attention and received treatment for the events. No lab diagnostics/studies were performed. It was reported that the patient was recovering and was slowly feeling better. On 08-AUG-2018, the patient was not feeling well (malaise) and his arms appeared extremely swollen and red at the area of injection which was 9 inches in length and 4 inches in diameter. On the same day, the patient sought medical attention at an unspecified location and was diagnosed with an infection (vaccination site infection). The patient was prescribed cephalexin as the treatment for the event. At the time of this report, the events of vaccination site infection and malaise was not resolved. Causality assessment was not provided. No product quality complaint was reported. The reporter considered the events; vaccination site inflammation, pain in extremity, pyrexia, influenza like illness, chills and poor-quality sleep to be cause of significant disability or incapacity as he was temporarily incapacitated and could not drive a car. The reporter considered the event pyrexia (also reported as it could be because of the high fever) to be life threatening.
tenitis worsen; This spontaneous case was reported by a consumer and describes the occurrence of TENDONITIS (tenitis worsen) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TENDONITIS (tenitis worsen). At the time of the report, TENDONITIS (tenitis worsen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter. Treatment details not reported by the reporter.
5pm, took 800 ibruprophen 6pm, cold and chills 7pm, chills, low grade fever 7pm - 11pm, chills, fatigue,  fever increased to 102.9 11pm - 5am, chills, fatique, fever all through the night. 5am - showered to go to work and couldn't think afterwards, started dry heaving, called off work. 530am  and on, slept on and off all day on 2/9 2/10 went to work, didn't feel normal most of the day 2/10 7pm started to get a sore neck 2/11 6am still have sore neck, hard to move neck, headache started.  8am took tylenol
anaphylaxis - Trouble swallowing food and water. Subsided after 24 hours Rashes on skin - itching - continue Took Tylenol and Zyrtec  Need frequent Zyrtec every 3 days for rashes
18 hours after booster injection had bad headaches, body aches, fever & chills, diarrhea, nausea
2 hr. after getting TDAP she started to experience slight dizziness & weakness when walking - sl. tightness in her throat, numbness in her face, sore eyes - blurred vision in both eyes that comes & goes.
Severe shoulder pain around injection site. Sharp pain including aching. Unable to lift or move arm without severe pain. Pain is now going on for 11 days. First 5 days were intense and severe. I was taking ibuprofen and Tylenol to help. Then the pain got better for 4 days. Day 10 the pain is back and severe again. Can?t move my arm without severe pain. Cannot lift it or sleep on it. Pain is in the shoulder area and also radiates up the neck at times and aches down to the forearm at times.
This spontaneous case reported by a consumer, describes the occurrence of administered product to patient of inappropriate age (his son, who is 14 years of age, mistakenly given the Moderna COVID-19 vaccine) in a 14-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Sep 21, 2021, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Sep 21, 2021, patient  administered product to patient of inappropriate age (his son, who is 14 years of age, mistakenly given the Moderna COVID-19 vaccine). At the time of the report,  administered product to patient of inappropriate age (his son, who is 14 years of age, mistakenly given the Moderna COVID-19 vaccine) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant product use or treatment information reported. Reporter stated he and his son went to receive the COVID-19 vaccine. His son (14 years of age) was mistakenly given the Moderna COVID-19 vaccine instead of the Pfizer vaccine. Reporter stated so far, his son seems fine.
Brain fog; pain in the neck; sore arm on injection site; Severe chills; High fever; This spontaneous case was reported by a patient and describes the occurrence of NECK PAIN (pain in the neck), VACCINATION SITE PAIN (sore arm on injection site), CHILLS (Severe chills), PYREXIA (High fever) and FEELING ABNORMAL (Brain fog) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced NECK PAIN (pain in the neck), VACCINATION SITE PAIN (sore arm on injection site), CHILLS (Severe chills) and PYREXIA (High fever). On 23-Jan-2021, the patient experienced FEELING ABNORMAL (Brain fog). At the time of the report, NECK PAIN (pain in the neck), VACCINATION SITE PAIN (sore arm on injection site), CHILLS (Severe chills), PYREXIA (High fever) and FEELING ABNORMAL (Brain fog) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Period was 8 days late.; "relatively robust immune response after the second dose (body aches, fever, chills, dizziness)"; "relatively robust immune response after the second dose (body aches, fever, chills, dizziness)"; "relatively robust immune response after the second dose (body aches, fever, chills, dizziness)"; "relatively robust immune response after the second dose (body aches, fever, chills, dizziness)"; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 25Mar2021 at 18:45 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Concomitant medications included IMPLANON for birth control since an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, after receiving the second dose, the patient's period was 8 days late. The patient had been diligently tracking her period for over 3 years and had a 28 day cycle on the dot every month with no period arriving early or late. She had a relatively robust immune response after the second dose (body aches, fever, chills, dizziness). The vaccine was the only change to her body that she able to isolate that would have affected her cycle. There were no other changes in her diet, habits or stress levels at the time of this report. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events period was 8 days late and "robust immune response after the second dose (body aches, fever, chills, dizziness)" were resolved on an unknown date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Injection site which was burning; Injection site which was itchy; Rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site which was burning), VACCINATION SITE PRURITUS (Injection site which was itchy) and VACCINATION SITE RASH (Rash at the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Injection site which was burning), VACCINATION SITE PRURITUS (Injection site which was itchy) and VACCINATION SITE RASH (Rash at the injection site). On 22-Feb-2021, VACCINATION SITE WARMTH (Injection site which was burning), VACCINATION SITE PRURITUS (Injection site which was itchy) and VACCINATION SITE RASH (Rash at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.    No treatment information was provided.    This case was linked to US-MODERNATX, INC.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Reporter name, address and email address were updated. On 29-Jul-2021: Follow-up received included no new information.; Sender's Comments:  US-MODERNATX, INC:Dose 2 case
MYOCARDITIS.  Patient is a 16 year old boy with ADHD who presented with fever and myalgias for 3 days, that progressed to sharp parasternal chest pain and some SOB. Patient received second dose Pfizer COVID-19 vaccine on 4/26, and after that shot experienced fever to 102 at home and myalgias. Subsequently his symptoms of chest pain have occurred. He underwent workup revealing of elevated Troponin, and EKG with some ST segment elevation, a slightly elevated CRP at 32, and a normal ECHO. Admitted for observation and concern for infectious myocarditis vs MIS-C. Cardiac MRI was done confirming Myocarditis, Troponin I was elevated and peaked at 23, 325pg/mL. Workup unrevealing of SARS. Other testing showed Resp virus panel negative, blood pcr for EBV, CMV, Parvovirus B19, enterovirus, and adenovirus all negative, HIV antigen/antibody testing negative. Patient treated with Ketorolac with steady improvement in symptoms over several hospital days. Discharged home 5/2 with Troponin I well down and symptoms resolved. Given reports in lay press regarding other cases of COVID-19 MRNA vaccine associated myocarditis, we are reporting this as a vaccine associated adverse event.
Booster #2 given too early.  Patient is 40YO and not immunocompromised.  Received Janssen as primary dose.  Moderna as Booster #1.  No adverse effect/event.  Reporting procedural error only.
On 06/11/2022 I started having a terrible runny nose and I thought it was my allergies. The next day I started having a funny feeling in my head and a coughing fit where I could hardly get my breath.  I knew that something was wrong so I did a home test and it was positive, then I went to a drive through testing site and had a pcr test which was also positive. My symptoms were runny nose, cough, low grade fever and feeling tired. I started Paxlovid on 06/13/22 and by the next day my symptoms were gone.
Information has been received from a healthcare worker (certified medical Assistant (C.M.A)) concerning a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not provided. On 06-FEB-2015, the patient was administered with a dose of improperly stored ZOSTAVAX (lot#, expiration date and dose not provided), subcutaneously. No adverse effects were reported. This one of several reports received from the same source. Additional information has been requested.
Generalized aching; Nausea; Low grade fever; Chills; Headache; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN (Generalized aching), NAUSEA (Nausea), PYREXIA (Low grade fever), CHILLS (Chills) and HEADACHE (Headache) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ADALIMUMAB (HUMIRA) and SODIUM CITRATE (CITRATE).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Generalized aching), NAUSEA (Nausea), PYREXIA (Low grade fever), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, PAIN (Generalized aching), NAUSEA (Nausea), PYREXIA (Low grade fever), CHILLS (Chills) and HEADACHE (Headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: Low.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant medications include  HUMIRA and  CITRATE  Treatment details were not reported.   Reporter did not allow further contact
shingles; Information has been received from a lawyer and a patient of unknown age and gender regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. In 2007, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot# and route unknown) for the long-term prevention of shingles and zoster-related conditions. Subsequent to the inoculation (date not reported), the patient was treated by a heath care provider for shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the event shingles was not recovered. The causality assessment was considered as related by the lawyer.
This spontaneous report as received from a registered nurse via company representative refers to a 60 year old female patient. The patient's pertinent medical history and drug reactions or allergies were not reported. On 09-NOV-2015, the patient was vaccinated subcutaneously with an unknown ZOSTAVAX (lot # and expiry date were not reported). Concomitant medications were not reported. On an unknown date in November 2015, after receiving a dose of ZOSTAVAX, the patient experienced swelling, redness, unspecified rash and warm to the touch 2 inches around the injection site. The patient sought medical attention via see the physician on 11-NOV-2015. The patient was informed to apply hydrocortisone cream to the injection site and to take ZYRTEC and BENADRYL. The outcome of the events was reported as recovering. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
pain @ base of neck & shoulders-hasn't subsided yet;also has pain @ inj site;took APAP;shoulder red;
Pharmacist described it as a seizure. Went unconscious, lost muscle control, lost vision and had ringing in ears.
Big 4" swelling next morning. The 2nd day in the morning much worse, by evening expanded, whole arm and neck sore. reaction site about 10 X 4". I have pictures if I can upload.
Patient presented to the ED and was subsequently hospitalized for acute appendicitis with perforation within 6 weeks of receiving covid vaccination.
Random spotting and cramping after getting vaccine for a day (Thursday). Wasn?t supposed to get my period as it had already ended a few days prior. Spotting only lasted for the day.
At about 2 minutes after the vaccine was administered patient began to c/o feeling hot and of tingling in left arm. Patient appeared diaphoretic with redness to bilateral cheeks and forehead. Patient was assessed by EMT and noted to have elevated blood pressure and pulse. Patient was offered and accepted fluids. Patient v/s was checked again by EMT and was decreased from previous. At about 20-25 min after onset of symptoms patient reported that she was feeling better and declined further treatment.